C

CytoTools AG
XETRA:T5O

Watchlist Manager
CytoTools AG
XETRA:T5O
Watchlist
Price: 101.26 EUR 0.98%
Market Cap: 52.8m EUR
Have any thoughts about
CytoTools AG?
Write Note

CytoTools AG
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CytoTools AG
Operating Income Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
C
CytoTools AG
XETRA:T5O
Operating Income
-€685.5k
CAGR 3-Years
20%
CAGR 5-Years
8%
CAGR 10-Years
1%
BioNTech SE
NASDAQ:BNTX
Operating Income
€908m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Operating Income
-€440.4m
CAGR 3-Years
-30%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Operating Income
-€101.7m
CAGR 3-Years
-13%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Operating Income
€229.8m
CAGR 3-Years
N/A
CAGR 5-Years
90%
CAGR 10-Years
15%
Formycon AG
XETRA:FYB
Operating Income
-€369k
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is CytoTools AG's Operating Income?
Operating Income
-685.5k EUR

Based on the financial report for Jun 30, 2023, CytoTools AG's Operating Income amounts to -685.5k EUR.

What is CytoTools AG's Operating Income growth rate?
Operating Income CAGR 10Y
1%

Over the last year, the Operating Income growth was 63%. The average annual Operating Income growth rates for CytoTools AG have been 20% over the past three years , 8% over the past five years , and 1% over the past ten years .

Back to Top